Sökning: "Colon cancer biomarkers"

Visar resultat 11 - 15 av 27 avhandlingar innehållade orden Colon cancer biomarkers.

  1. 11. HER3 expression and prognosis in colon and rectal cancer

    Författare :Frida Lédel; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Colorectal cancer;

    Sammanfattning : In Sweden, about 6000 patients get a colorectal cancer diagnosis annually. Advances in management of both colon and rectal cancer have reduced mortality even though the incidences are increasing. LÄS MER

  3. 12. Estrogen signaling in colon inflammation and colorectal cancer

    Författare :Linnea Hases; Cecilia Williams; Joëlle Rüegg; KTH; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Medical Technology; Medicinsk teknologi;

    Sammanfattning : Colorectal cancer (CRC) is the third most deadly form of cancer in the Western world. Although screening efforts have reduced the overall mortality, the incidence is increasing among young adults. LÄS MER

  4. 13. Genetic Analyses of Tumor Progression in Colorectal Cancer

    Författare :Kristina Lagerstedt; Göteborgs universitet; []
    Nyckelord :colorectal cancer; tumor progression; microarray; DNA aberration; gene expression; microRNA; structural variation;

    Sammanfattning : Colorectal tumors are responsible for more than 600 000 deaths per year worldwide and thereby constitute the second most common cause of cancer related mortality. Early detection is related to improved prognosis and identification of genetic biomarkers would meliorate available diagnostic tools. LÄS MER

  5. 14. Biomarker mRNAs for staging and prognosis of colorectal cancer

    Författare :Lina Ohlsson; Marie-Louise Hammarström; John Shively; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; colorectal cancer; immunologi; Immunology;

    Sammanfattning : Mesenteric lymph node (ln) metastasis is the single most important prognostic characteristic in colorectal cancer (CRC). The ln status is used for staging and is a decisive selection criterion for postoperative adjuvant therapy. However, it is difficult to accurately determine ln status by routine histopathology (H&E). LÄS MER

  7. 15. Colon cancer : disease related proteins in tumor tissue and serum

    Författare :Uwe Johannes Roblick; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Despite the progress in surgical techniques and adjuvant therapies the mortality of around 60% within the group of colon cancer patients did not decrease significantly over the last decades. This determines a growing demand for biomarkers for early detection, prognosis and risk assessment in colorectal malignancies. LÄS MER